Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Sells Mayo Foundation on P450-2D6 Test

NEW YORK, Sept. 17 (GenomeWeb News) - Tm Bioscience of Toronto today announced that the Mayo Foundation has signed a two-year agreement to purchase the Tm Tag-It brand P450-2D6 drug metabolism test.


The Mayo Foundation of Rochester, Minn., will used the product in the Mayo Medical Laboratories, a facility that provides lab testing services for Mayo as well as other medical centers and hospitals, Tm said in a statement.


Tm's P450-2D6 test was launched in June. The company said that Mayo has begun internal validation tests for the product through an early access agreement.


The P450-2D6, a test that is designed to identify the presence or absence of mutations common in patients with atypical drug metabolism, is based on Tm's universal array platform and operates on the Luminex xMAP system.


The sale of such a microarray-based product is not without controversy. In June, Roche launched its own P450 microarray-based test only to receive a letter from the US Food and Drug Administration questioning the propriety of marketing a microarray-based test as an analyte specific reagent.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.